NL-OMON27646尚未招募不适用
Anti-CD20 therapy for the treatment ofchronic graft versus host disease.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age > 18 yr;
- •2. Steroid refractory chronic GVHD, including skin localization;
- •3. No other treatment apart from steroids and when applicable standard GVHD prevention.
排除标准
- •1. Relapse with a life expectancy of < 6 months;
- •3. Severe infections.
研究者
相似试验
已完成
不适用
ANTI-CD20 THERAPY FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASEchronic graft-versus-host disease, allogeneic stem cell transplantation, B-cell depletionNL-OMON27822niversity Medical Centre UtrechtP.O. Box 855003508 GA Utrecht, The Netherlands30
已完成
不适用
Anti-CD20 therapy for the treatment of chronic Graft Versus Host DiseaseChronic Graft Versus Host Disease (cGVHD)Injury, Occupational Diseases, PoisoningFailure and rejection of transplanted organsISRCTN43525354niversity Medical Center Utrecht (UMCU) (The Netherlands)30
已完成
不适用
Anti-CD20 treatment of relapsed or refractory Immune Thrombocytopenic Purpura (ITP) after first line corticosteroid treatment.NL-OMON23430150
已完成
不适用
Anti-CD20 treatment of relapsed or refractory immune thrombocytopaenic purpura (ITP) after first line corticosteroid treatmentImmune thrombocytopaenic purpura (ITP)Haematological DisordersPurpura and other haemorrhagic conditionsISRCTN16619820Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (The Netherlands) - Data Centre150
已完成
不适用
Anti-CD20 monoclonal antibody therapy for type II mixed cryoglobulinemia syndromeMixed cryoglobulinemia HCV- related or unrelatedHaematological DisordersCryoglobulinaemiaISRCTN55287110niversity of Udine (Italy)124